Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 2 (1)
P 3 (2)
P 4 (2)

Trial Status

Not Yet Recruiting3
Completed3
Unknown2
Terminated2
Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (11)

Research Network

Activity Timeline